Purchase Order 75N95023P00761
Award Date 9/11/23
Potential Completion Date 9/10/28
Potential Value $139K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Wilmington, DE 19802, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to The Emmes Company LLC, a global clinical research organization, by the National Institute on Drug Abuse (NIDA), a civilian agency. The $1,397,874.58 contract is for data and statistical analysis support for a study on the use of GLP-1 as an adjunct to buprenorphine for the treatment of substance use disorders. The contract, awarded on May 21, 2025, has a period of performance from May 21, 2025 to February 29, 2028. It is a cost-plus-fixed-fee Delivery Order...
- The National Institute on Drug Abuse (NIDA) awarded a $1,510,879.00 cost-plus-fixed-fee delivery order contract to The Emmes Company LLC for the project "OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100)." The contract period of performance is from August 15, 2024 to March 31, 2028. This task order is placed under NIDA's $31 million Indefinite Delivery Vehicle for data, statistics, and clinical trial support services. The...
- The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $233,971.50 firm fixed-price delivery order to GLC On-The-Go, Inc. for Contractual Pharmaceutical Support for the NIDA Intramural Research Program (IRP). The contract is set aside for small businesses and has a period of performance from September 5, 2023 to September 4, 2024, with a total period of performance through September 4, 2028. GLC On-The-Go, Inc. is a minority-owned, woman-owned small business that specializes...
- The U.S. National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, awarded a $10,000.00 labor-hour purchase order contract to Christoph Kahl, a small business located in Thousand Oaks, California. The contract is for pharmaceutics formulation and chemistry manufacturing and controls (CMC) consulting services to support NIDA's drug discovery and development programs, including the NIH Blueprint Neurotherapeutics, Help End Addiction Longterm...
- The National Institute on Drug Abuse (NIDA) awarded a $525,738.00 cost-plus-fixed-fee delivery order contract to The Emmes Company LLC, a for-profit limited liability company, to conduct a randomized, placebo-controlled trial of injectable naltrexone and monthly injectable buprenorphine for the treatment of cocaine use disorder. The contract runs from August 15, 2024 to March 31, 2026 and is not set aside for any specific business type. The Emmes Company LLC is a global clinical research...
- The National Institute on Drug Abuse awarded a $79,569.86 firm fixed-price purchase order to Salient Science & Technology LLC for pharmaceutical business development consulting services. The contract, designated as a Total Small Business set-aside, was awarded on February 27, 2017, with an ultimate completion date of April 14, 2022. Work is being performed in Bethesda, Maryland, and the engagement focuses on business development consulting support for the institute's pharmaceutical...
- The National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, awarded a $54,000.00 labor-hour purchase order contract to RPK Associates, LLC, a small business, for pharmaceutics formulation and chemistry manufacturing and controls (CMC) consulting services for small molecules and/or biologics. The contract has a base period from September 20, 2025, through September 19, 2026, with optional hours up to 800 total hours per consultant annually. The services...
- <p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>
- The National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, awarded a $20.2K labor-hour purchase order to Araldi Gian Luca, a sole proprietorship specializing in pharmaceutical and neuroscience research consulting. This total small business set-aside contract, effective through September 28, 2028, provides pharmaceutics formulation and chemistry manufacturing and controls (CMC) consulting services to support NIDA's drug discovery and development initiatives,...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Alcami Carolinas Corporation for a project titled "GLWL-01 CAPSULE AND PLACEBO STABILITY PROGRAM. MANIPULATING GHRELIN SIGNALING VIA GOAT INHIBITION IN ALCOHOL USE DISORDER TESTING". The contract has a ceiling value of $85,652.00 and a period of performance ending on August 4, 2025. The contract was awarded on a sole-source basis without a set-aside, as...